for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-FDA Says Issued EUA For Eli Lilly's Investigational Monoclonal Antibody Therapy Bamlanivimab For Treatment Of Covid-19

Nov 9 (Reuters) -

* FDA SAYS ISSUED EUA FOR ELI LILLY’S INVESTIGATIONAL MONOCLONAL ANTIBODY THERAPY BAMLANIVIMAB FOR TREATMENT OF COVID-19

* FDA SAYS AUTHORIZES MONOCLONAL ANTIBODY THERAPY BAMLANIVIMAB FOR TREATMENT OF COVID-19 IN ADULT AND PEDIATRIC PATIENTS Source text: bit.ly/3llMPrS Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up